Author(s): Shalini K. Sawhney, Chaitanya Narayan, Achal Mishra, Monika Singh, Avneet Kaur


DOI: 10.52711/0974-360X.2024.00053   

Address: Shalini K. Sawhney1*, Chaitanya Narayan1, Achal Mishra2, Monika Singh1, Avneet Kaur3
1ITS College of Pharmacy, Muradnagar, Ghaziabad, U.P., India.
2Faculty of Pharmaceutical Sciences Shri Shankaracharya Technical Campus, Bhilai, Chhattishgarh, India
3SGT College of Pharmacy, SGT University, Gurgaon, India.
*Corresponding Author

Published In:   Volume - 17,      Issue - 1,     Year - 2024

The twelve most effective dibenzo-a-pyrone derivatives as anticonvulsant chemicals have been chosen from our earlier study, and their 2D structures have been determined. Using Spartan'14 version 1.1.2, the compounds' 3D structures were generated, optimized, and transferred in PDB format. Molecular docking investigations of effective anticonvulsant drugs utilized the Toshiba Satellite, Dual-core CPU, Windows 8 operating system, and the AutoDockVina of PyRx virtual screening program. PyRx was activated with the flexible docking option to dock the GABAAT enzyme, NMDA, and dibenzo-a-pyrone derivatives (Ligands) into the X, Y, and Z coordinate systems. Some Dibenzo- a -pyrone compounds were studied for their antiepileptic efficacy by molecular docking, absorption, distribution, metabolism, and toxicity. Docking analysis revealed that all the compounds have good binding scores, and SS9 derivative has the highest binding score compared to others in both the targets selected. ADME results revealed that most parameters are within limits, and toxicity analysis suggested that the designed compounds are low in toxicity. This research on molecular docking gives a valued insight for medicinal and pharmaceutical chemists to synthesize more derivatives of designed Dibenzo-a-pyrone compounds as lead for antiepileptic drugs, which would be more effective for managing convulsions.

Cite this article:
Shalini K. Sawhney, Chaitanya Narayan, Achal Mishra, Monika Singh, Avneet Kaur. Molecular Docking, ADME and Toxicity Study of Dibenzo-α-pyrone derivatives for GABA and NMDA receptors for their antiepileptic activity. Research Journal of Pharmacy and Technology. 2024; 17(1):340-6. doi: 10.52711/0974-360X.2024.00053

Shalini K. Sawhney, Chaitanya Narayan, Achal Mishra, Monika Singh, Avneet Kaur. Molecular Docking, ADME and Toxicity Study of Dibenzo-α-pyrone derivatives for GABA and NMDA receptors for their antiepileptic activity. Research Journal of Pharmacy and Technology. 2024; 17(1):340-6. doi: 10.52711/0974-360X.2024.00053   Available on:

1.    Prilipko L. De Boer MH, Dua T. Bertolote J. Epilepsy care—the WHO/ILAE/IBE global campaign against epilepsy. US Neurological Disease. 2006; 39-40. 10.1111/j.1528-1167.2006.00595.x
2.    Maertens P. Dyken P. Graf W. Pippenger C. Chronister R. Shah A. Free radicals, anticonvulsants, and the neuronal ceroid‐lipofuscinoses. American Journal of Medical Genetics. 1995; 57(2): 225-8.
3.    Torbati D. Church DF. Keller JM. Pryor WA. Free radical generation in the brain precedes hyperbaric oxygen-induced convulsions. Free Radical Biology and Medicine. 1992; 13(2): 101-6. 10.1016/0891-5849(92)90070-w
4.    Jesberger JA. Richardson JS. Oxygen free radicals and brain dysfunction. International Journal of Neuroscience. 1991; 57(1-2): 1-7.
5.    Karlsson A. Fonnum F. Malthe-Sørenssen D. Storm-Mathisen J. Effect of the convulsive agent 3-mercaptopropionic acid on the levels of GABA, other amino acids and glutamate decarboxylase in different regions of the rat brain. Biochemical Pharmacology. 1974; 23(21): 3053-61. 10.1016/0006-2952(74)90281-0
6.    Krogsgaard-Larsen P. gamma.-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects. Journal of Medicinal Chemistry. 1981; 24(12): 1377-83. 10.1021/jm00144a001
7.    Storici P, Capitani G. De Biase D. Moser M. John RA. Jansonius JN. Schirmer T. Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy. Biochemistry. 1999; 38(27): 8628-34. 10.1021/bi990478j
8.    White HS. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia. 1999; 40: 1999.tb00913.x
9.    Xu T. Bajjalieh SM. SV2 modulates the size of the readily releasable pool of secretory vesicles. Nature Cell Biology. 2001; 3(8): 691-8. 10.1038/35087000
10.    Dichter MA. Brodie MJ.,1996. New antiepileptic drugs. English J. Med. 336, 1583– 90. 10.1056/NEJM199606133342407
11.    Brodie MJ. Shorvon SD. Canger R. Halasz P. Johannessen S. Thompson P. Wieser HG. Wolf P. Commission on European Affairs: appropriate standards of epilepsy care across Europe. Epilepsia. 1997; 38(11): 1245-50.
12.    Wang R., Reddy P. H. Role of glutamate and NMDA receptors in Alzheimer’s disease. Journal of Alzheimer’s Disease. 2017; 57(4): 1041–1048. doi: 10.3233/jad-160763.
13.    Joshi GG. Tewari KC. Pande NK. Pande G. Bryophyte, the source of the origin of Shilajit–a new hypothesis. BMEBR. 1994; 15(1-4):106-11.
14.    Ghosal S. Mukhopdhyay B. Muruganandam. Ayurvedicherbo-mineral vitalizer: ancient and modern perspective; Indian Journal of Indigenous Medicines. 1995; 17(2): I -12.
15.    Ghosal S.  Reddy JP. Lal VK. Shilajit I. Chemical constituents. Journal of Pharmaceutical Sciences. 1976; 65(5): 772-3.
16.    Sawhney SK. Shrivastava B. Kumara Y. Shrivastava V.  Sahai A. Synthesis, characterization and antimicrobial activity of some dibenzo-α-pyrone derivatives. Der Chemica Sinica. 2014; 5(3):10-14  
17.    Hurtley WR. CCXLIV.—Replacement of halogen in ortho bromo-benzoic acid. Journal of the Chemical Society (Resumed). 1929: 1870-3.  
18.    Sawhney SK. Agarwal NB.  Kumar Y. Shrivastava B. Sharma P. Anticonvulsant And Antioxidant Actions Of Some Dibenzo-a-Pyrone Derivatives In Pentylene –Induced Kindling Model In Mice.  Drug Invention Today 2015; 7(1): 9-14
19.    Wilk IJ. Chemical aspects of anticonvulsant drugs. J Chem Educ. 1957;
20.    Yuriev E. Agostino M. Ramsland PA. Challenges and advances in computational docking: 2009 in review. Journal of Molecular Recognition. 2011; 24(2): 149-64. 10.1002/jmr.1077
21.    Abraham D. Burger’s Medicinal Chemistry and Drug Discovery 6th ed Volume 1: Drug Discovery.  
22.    Abdulfatai U. Uzairu A. Uba S. Quantitative structure activity relationship study of anticonvulsant activity of α_substituted acetamido-N-benzylacetamide derivatives. Cogent Chemistry. 2016; 2(1)
23.    Abdulfatai U. Uba S. Umar BA.  Ibrahim MT. Molecular design and docking analysis of the inhibitory activities of some α_substituted acetamido-N-benzylacetamide as anticonvulsant agents. SN Applied Sciences. 2019 ; 1(5): 1-8. 10.1007/s42452-019-0512-6
24.    Otukere IE. Amaku FJ. Alisa CO. In Silaco Geometry Optimization, Excited-State Properties of (2E)-N-Hydroxy-3-[-(Phenylsulfamoyl) Phenyl]prop-2-Enamide (Belinostat) and its Molecular Docking Studies with Ebola Virus Glycoprotein. Asian Journal of Pharmaceutical Research. 2015; 5(3): 131-137. doi10.5958/2231-5691.2015.00020.9
25.    Hemlata K. Selvin J, Girija K. Synthesis, In silico Molecular Docking Study and Anti-bacterial Evaluation of some Novel 4-Anilino Quinazolines. Asian Journal of Pharmaceutical Research. 2018; 8(3): 125-132. doi10.5958/2231-5691.2018.00022.9
26.    Patadiya N. Vaghela V. Design, in-silico ADME Study and molecular docking study of novel quinolone-4—on derivatives as Factor Xa Inhibitor as Potential anti-coagulating agents. Asian Journal of Pharmaceutical Research. 2022; 12(3): 207-1. doi10.52711/2231-5691.2022.00034
27.    Hemlata K. Girija K. Evaluation of Drug Candidature of some Benzimidazole Derivatives as Biotin Carboxylase Inhibitors: Molecular docking and Insilico studies. Asian Journal of Research in Pharmaceutical Sciences.2016; 6(1): 15-20. doi10.5958/2231-5659.2016.00002.3
28.    Sindhu TJ. Arathi KN. Devi A. Awathi TA. Naushida M. Midhun M. Kuttiyil SS. Synthesis, Molecular Docking and Antibacterial Studies of Novel Azole derivatives as Enoyl ACP Reductase Inhibitor in Escherichia coli. Asian Journal of Research in Pharmaceutical Sciences. 2019; 9(3): 174-180. doi10.5958/2231-5659.2019.00027.4
29.    Bhardwaj S. Dubey S. Qsar and Docking studies of some novel piperine analogues as monoamine oxidase inhibitors. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(2): 115-2. doi10.52711/2231-5659.2022.00019
30.    Devgan M. Homology modelling and molecular docking studies of DNA replication licencing factor minichromosome maintenance protein 5(MCM5).  Asian Journal of Pharmacy and Technology. 2015; 5(1): 17-22 doi10.5958/2231-5713.2015.00004.5
31.    Chandran M. George S. Santhalingam K. Gangwar P. Rajasekar D. Molecular docking of 3, 5, 7-Trihydroxy-2-(4-hyroxy-3-methoxyphenyl)-4hChromen-4-one derivatives against II-6 for rheumatoid arthritis. Asian Journal of Research in Chemistry. 2011; 4(8): 1254-57.  
32.    Sravani M. Duganath N. Gade DR. Reddy CHS. Insilico analysis and docking of Imatinib derivatives targeting BCR-ABL oncoprotein for chronic myeloid leukemia. Asian Journal of Research in Chemistry. 2012;5 (1):153-58.  
33.    Dhananjayan K. Sumathy A. Palanisamy S. Molecular docking studies and in-vitro acetylcholinestrase inhibition by terpenoids and flavonoids. Asian Journal of Research in Chemistry.   2013; 6(11): 1011-17 (
34.    Kohn H. Conley JD. Leander JD. Marked stereospecificity in a new class of anticonvulsants. Brain Research. 1988; 457(2): 371-5. 10.1016/0006-8993(88)90709-3
35.    Hehre WJ. Huang WW. Chemistry with computation: an introduction to SPARTAN. Irvine: 10.4236/ojpc.2015.53006  
36.    Trott O.  Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry. 2010 ; 31(2): 455-61. 10.1002/jcc.21334
37.    Biovia, Dassault Systèmes, BIOVIA Workbook, Release 2020; Biovia Pipeline Pilot, Release 2020, San Diego: Dassault Systèmes.  
38.    Sambasivarao SV. Roberts J. Bharadwaj VS. Slingsby JG. Rohleder C. Mallory C. Groome JR. McDougal OM.  Maupin CM. Acetylcholine Promotes Binding of α‐Conotoxin MII at α3β2 Nicotinic Acetylcholine Receptors. Chembiochem. 2014; 15(3): 413-24.
39.    Lagorce D. Sperandio O. Galons H. Miteva MA. Villoutreix BO. FAF-Drugs 2: free ADME/tox filtering tool to assist drug discovery and chemical biology projects. BMC Bioinformatics. 2008; 9(1):1-9.
40.    Pires DE. Blundell TL. Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of medicinal chemistry. 2015; 58(9):

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available